A series of <i>N</i>-substituted (2-phenylcyclopropyl)methylamines were designed and synthesized, with the aim of finding serotonin 2C (5-HT<sub>2C</sub>)-selective agonists with a preference for G<sub>q</sub> signaling. A number of these compounds exhibit 5-HT<sub>2C</sub> selectivity with a preference for G<sub>q</sub>-mediated signaling compared with β-arrestin recruitment. Furthermore, the <i>N-</i>methyl compound (+)-<b>15a</b>, which displayed an EC<sub>50</sub> of 23 nM in the calcium flux assay while showing no β-arrestin recruitment activity, is the most functionally selective 5-HT<sub>2C</sub> agonist reported to date. The <i>N</i>-benzyl compound (+)-<b>19</b>, which showed an EC<sub>50</sub> of 24 nM at the 5-HT<sub>2C</sub> re...
Since the 1950s, when serotonin (5-HT) was discovered in the mammalian central nervous system (CNS),...
The 5-HT2 receptor is one member of the serotonin (5-HT) receptor family and consists of at least th...
A conformationally restricted analog of a selective cyclopropane-bearing serotonin 2C agonist was de...
A series of N-substituted (2-phenylcyclopropyl)methylamines were designed and synthesized, with the ...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
The discovery of a new series of compounds that are potent, selective 5-HT<sub>2C</sub> receptor ago...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
A series of novel compounds with two halogen substituents have been designed and synthesized to furt...
On the basis of the structural similarity of our previous 5-HT<sub>2C</sub> agonists with the melato...
A series of novel compounds with two halogen substituents have been designed and synthesized to furt...
On the basis of the structural similarity of our previous 5-HT2C agonists with the melatonin recepto...
A new series of fluorinated 5-HT2C agonists were designed and synthesized on the basis of our previo...
(Chemical Equation Presented) Treating neurological conditions: Optimization of a previously identif...
We report here the design, synthesis, and pharmacological properties of a series of compounds relate...
The 5-HT2C receptor is an attractive drug target in the quest for new therapeutics to treat a variet...
Since the 1950s, when serotonin (5-HT) was discovered in the mammalian central nervous system (CNS),...
The 5-HT2 receptor is one member of the serotonin (5-HT) receptor family and consists of at least th...
A conformationally restricted analog of a selective cyclopropane-bearing serotonin 2C agonist was de...
A series of N-substituted (2-phenylcyclopropyl)methylamines were designed and synthesized, with the ...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
The discovery of a new series of compounds that are potent, selective 5-HT<sub>2C</sub> receptor ago...
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is de...
A series of novel compounds with two halogen substituents have been designed and synthesized to furt...
On the basis of the structural similarity of our previous 5-HT<sub>2C</sub> agonists with the melato...
A series of novel compounds with two halogen substituents have been designed and synthesized to furt...
On the basis of the structural similarity of our previous 5-HT2C agonists with the melatonin recepto...
A new series of fluorinated 5-HT2C agonists were designed and synthesized on the basis of our previo...
(Chemical Equation Presented) Treating neurological conditions: Optimization of a previously identif...
We report here the design, synthesis, and pharmacological properties of a series of compounds relate...
The 5-HT2C receptor is an attractive drug target in the quest for new therapeutics to treat a variet...
Since the 1950s, when serotonin (5-HT) was discovered in the mammalian central nervous system (CNS),...
The 5-HT2 receptor is one member of the serotonin (5-HT) receptor family and consists of at least th...
A conformationally restricted analog of a selective cyclopropane-bearing serotonin 2C agonist was de...